Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2e9z | UTP | Genome polyprotein |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
2e9z | UTP | Genome polyprotein | / | 1.000 | |
3n6m | GTP | Genome polyprotein | / | 0.526 | |
3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.474 | |
2v3a | FAD | Rubredoxin-NAD(+) reductase | 1.18.1.1 | 0.462 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.462 | |
2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
1u3d | FAD | Cryptochrome-1 | / | 0.445 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.444 | |
3w0s | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.442 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.440 |